Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

John Rumsfeld

Concepts (596)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
99
2021
1212
6.200
Why?
Percutaneous Coronary Intervention
53
2021
549
5.090
Why?
Registries
104
2021
2382
4.480
Why?
Cardiology
31
2021
363
3.570
Why?
Angioplasty, Balloon, Coronary
39
2014
156
3.510
Why?
United States Department of Veterans Affairs
40
2017
777
3.070
Why?
Cardiovascular Diseases
38
2021
2218
3.020
Why?
Coronary Artery Disease
26
2021
751
2.480
Why?
Quality of Health Care
31
2020
692
2.430
Why?
Hospitals, Veterans
17
2016
256
2.380
Why?
Health Status
35
2018
822
2.380
Why?
Coronary Artery Bypass
23
2017
268
2.140
Why?
Quality Assurance, Health Care
23
2015
339
2.100
Why?
Coronary Disease
15
2013
380
2.030
Why?
Cardiac Catheterization
21
2018
569
1.870
Why?
Transcatheter Aortic Valve Replacement
18
2021
153
1.830
Why?
United States
175
2021
16041
1.810
Why?
Quality Indicators, Health Care
20
2020
340
1.810
Why?
Hospital Mortality
45
2021
1037
1.810
Why?
Coronary Angiography
20
2020
325
1.780
Why?
Platelet Aggregation Inhibitors
18
2018
499
1.720
Why?
Heart Failure
31
2016
2323
1.700
Why?
American Heart Association
28
2017
363
1.680
Why?
Aged
201
2021
26251
1.670
Why?
Hospitals
24
2017
730
1.620
Why?
Ticlopidine
10
2016
52
1.610
Why?
Quality of Life
32
2018
3187
1.530
Why?
Aortic Valve Stenosis
12
2021
254
1.440
Why?
Acute Coronary Syndrome
11
2017
299
1.440
Why?
Angina Pectoris
16
2016
76
1.430
Why?
Depression
20
2016
1566
1.400
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
11
2016
448
1.310
Why?
Myocardial Ischemia
13
2016
286
1.310
Why?
Angina, Unstable
13
2016
83
1.280
Why?
Humans
332
2024
145625
1.260
Why?
Practice Guidelines as Topic
22
2021
1581
1.200
Why?
Risk Assessment
48
2021
3678
1.200
Why?
Product Surveillance, Postmarketing
6
2015
74
1.180
Why?
Treatment Outcome
87
2021
11744
1.170
Why?
Aortic Valve
10
2021
360
1.150
Why?
Middle Aged
163
2021
36359
1.150
Why?
Heart Valve Prosthesis Implantation
7
2018
196
1.120
Why?
Male
220
2021
73014
1.120
Why?
Patient Selection
16
2016
720
1.100
Why?
Guideline Adherence
15
2017
585
1.080
Why?
Risk Factors
86
2021
10840
1.060
Why?
Female
217
2021
79080
1.050
Why?
Cholesterol, LDL
5
2015
363
1.050
Why?
Hospitalization
25
2016
2468
1.030
Why?
Patient Readmission
13
2017
771
1.010
Why?
Telemedicine
9
2021
956
1.010
Why?
Drug-Eluting Stents
11
2016
88
0.970
Why?
Wearable Electronic Devices
7
2024
75
0.970
Why?
Adrenergic beta-Antagonists
12
2011
252
0.970
Why?
Atrial Fibrillation
11
2021
559
0.950
Why?
Practice Patterns, Physicians'
14
2018
1370
0.950
Why?
Defibrillators, Implantable
10
2015
393
0.920
Why?
Biomedical Technology
3
2018
49
0.920
Why?
Models, Statistical
13
2019
667
0.920
Why?
Veterans
19
2016
1647
0.910
Why?
Multivariate Analysis
32
2017
1531
0.890
Why?
Electrocardiography
20
2021
666
0.830
Why?
Angiotensin-Converting Enzyme Inhibitors
9
2016
228
0.830
Why?
Data Mining
4
2019
113
0.820
Why?
Hypercholesterolemia
2
2015
95
0.810
Why?
Aged, 80 and over
62
2021
8351
0.810
Why?
Heart Valve Diseases
5
2017
150
0.800
Why?
Societies, Medical
10
2020
901
0.800
Why?
Quality Improvement
10
2020
1325
0.780
Why?
Diffusion of Innovation
3
2020
96
0.780
Why?
Veterans Health
5
2017
188
0.760
Why?
Time Factors
54
2019
7079
0.750
Why?
Continuity of Patient Care
4
2016
297
0.740
Why?
Cohort Studies
39
2021
6045
0.710
Why?
Angina, Stable
3
2016
18
0.700
Why?
Treatment Refusal
5
2008
98
0.680
Why?
Delivery of Health Care, Integrated
3
2020
304
0.680
Why?
Heart Rate
4
2021
844
0.680
Why?
Cardiac Care Facilities
2
2014
11
0.660
Why?
Retrospective Studies
62
2021
17291
0.660
Why?
Myocardial Revascularization
7
2016
85
0.650
Why?
Acute Kidney Injury
11
2019
861
0.650
Why?
Mortality
12
2017
375
0.640
Why?
Cardiac Surgical Procedures
6
2013
608
0.640
Why?
Arrhythmias, Cardiac
5
2020
358
0.630
Why?
Ezetimibe
2
2017
24
0.620
Why?
Delivery of Health Care
7
2018
942
0.620
Why?
Patient Discharge
11
2017
991
0.620
Why?
Postoperative Complications
16
2018
2962
0.610
Why?
Hospital Costs
3
2016
127
0.610
Why?
Simvastatin
2
2017
58
0.610
Why?
Follow-Up Studies
38
2021
5397
0.610
Why?
Disease Management
8
2020
649
0.600
Why?
Machine Learning
4
2021
590
0.600
Why?
Logistic Models
29
2017
2112
0.600
Why?
Patient-Centered Care
3
2018
551
0.600
Why?
Patient Satisfaction
8
2016
698
0.580
Why?
Exercise Test
9
2015
634
0.570
Why?
Heart Diseases
7
2012
341
0.570
Why?
Electronic Health Records
6
2014
1208
0.560
Why?
Myocardial Reperfusion
9
2010
57
0.560
Why?
Anticholesteremic Agents
2
2017
156
0.540
Why?
Sickness Impact Profile
5
2005
67
0.540
Why?
Cardiovascular Agents
6
2016
165
0.520
Why?
Health Status Indicators
5
2009
166
0.520
Why?
Evidence-Based Medicine
7
2018
727
0.510
Why?
Social Media
2
2019
158
0.510
Why?
Odds Ratio
24
2017
1070
0.500
Why?
Data Interpretation, Statistical
2
2016
365
0.500
Why?
Medical Informatics
2
2017
101
0.500
Why?
Monitoring, Physiologic
3
2021
278
0.500
Why?
Cost of Illness
5
2015
322
0.490
Why?
Aspirin
8
2016
404
0.490
Why?
Health Services Accessibility
5
2016
1101
0.490
Why?
Search Engine
1
2016
13
0.480
Why?
Proportional Hazards Models
18
2017
1318
0.480
Why?
Crowdsourcing
1
2016
18
0.480
Why?
Prospective Studies
39
2022
8087
0.470
Why?
Program Evaluation
5
2020
945
0.470
Why?
Stents
6
2014
551
0.460
Why?
Coronary Restenosis
4
2013
22
0.460
Why?
Postoperative Hemorrhage
6
2021
105
0.460
Why?
Stroke
16
2018
1283
0.460
Why?
Comorbidity
19
2019
1652
0.450
Why?
Emergency Medical Services
4
2016
680
0.450
Why?
Recovery of Function
3
2009
721
0.450
Why?
Cell Phone
1
2016
83
0.440
Why?
Hemorrhage
13
2018
824
0.430
Why?
Peer Review
1
2014
47
0.420
Why?
Survival Rate
19
2020
2078
0.410
Why?
Unnecessary Procedures
1
2014
54
0.410
Why?
Arterial Occlusive Diseases
1
2014
87
0.410
Why?
Incidence
22
2021
2910
0.410
Why?
Emergency Service, Hospital
7
2020
2357
0.410
Why?
Chi-Square Distribution
11
2017
511
0.400
Why?
Self Care
2
2015
396
0.400
Why?
Databases, Factual
6
2019
1481
0.400
Why?
Patient Care Team
3
2015
700
0.400
Why?
Health Policy
6
2017
399
0.400
Why?
Patient Compliance
8
2014
587
0.400
Why?
Prognosis
22
2020
4331
0.390
Why?
Mobile Applications
3
2021
193
0.380
Why?
Surveys and Questionnaires
25
2022
6050
0.370
Why?
Patient Education as Topic
3
2016
769
0.360
Why?
Patient Participation
1
2016
454
0.360
Why?
Health Services Research
6
2016
389
0.360
Why?
Antihypertensive Agents
6
2014
519
0.360
Why?
Age Factors
19
2017
3321
0.360
Why?
Acute Disease
12
2011
1033
0.360
Why?
Health Surveys
3
2013
511
0.350
Why?
Decision Support Techniques
4
2018
473
0.350
Why?
Survival Analysis
14
2010
1372
0.350
Why?
Severity of Illness Index
20
2017
2910
0.350
Why?
Hypertension
4
2014
1270
0.340
Why?
Physician's Role
1
2013
222
0.330
Why?
Patient Identification Systems
3
2016
16
0.330
Why?
Prescriptions
2
2010
74
0.330
Why?
Benchmarking
4
2021
192
0.330
Why?
Cardiac Output, Low
3
2006
53
0.330
Why?
Risk
11
2019
917
0.330
Why?
Kidney Failure, Chronic
5
2019
582
0.320
Why?
Cardiac Imaging Techniques
1
2010
24
0.320
Why?
Preventive Health Services
2
2015
154
0.320
Why?
Research Design
7
2016
1139
0.320
Why?
Hospital Information Systems
1
2010
15
0.310
Why?
Radial Artery
4
2017
74
0.310
Why?
Software
2
2014
673
0.310
Why?
Fibrinolytic Agents
7
2021
302
0.310
Why?
Drug Monitoring
2
2014
399
0.300
Why?
Monitoring, Ambulatory
2
2024
88
0.300
Why?
Predictive Value of Tests
11
2019
2097
0.300
Why?
Renal Dialysis
9
2019
458
0.300
Why?
Prostheses and Implants
1
2010
137
0.300
Why?
Medicare
10
2021
907
0.290
Why?
Randomized Controlled Trials as Topic
2
2015
1754
0.290
Why?
Precision Medicine
3
2018
462
0.290
Why?
Ambulatory Care
7
2015
627
0.290
Why?
Patient Transfer
3
2011
223
0.290
Why?
Mitral Valve Insufficiency
3
2018
69
0.290
Why?
Coronary Stenosis
3
2013
40
0.290
Why?
Autonomic Nervous System Diseases
1
2009
38
0.280
Why?
Sex Factors
9
2016
2101
0.280
Why?
Diabetes Mellitus
6
2014
1101
0.280
Why?
Health Plan Implementation
1
2010
143
0.280
Why?
Prevalence
17
2017
2852
0.270
Why?
Withholding Treatment
2
2010
77
0.270
Why?
Cardiology Service, Hospital
3
2020
29
0.270
Why?
Diabetic Angiopathies
2
2008
265
0.270
Why?
Proton Pump Inhibitors
1
2009
101
0.270
Why?
Depressive Disorder
3
2010
359
0.270
Why?
Receptor, Cannabinoid, CB1
1
2008
39
0.270
Why?
Renal Insufficiency, Chronic
5
2017
639
0.260
Why?
Surgical Wound Infection
1
2011
331
0.260
Why?
Mental Disorders
2
2007
1133
0.260
Why?
Syndrome
6
2007
377
0.250
Why?
Regression Analysis
8
2009
994
0.250
Why?
Data Collection
6
2017
647
0.250
Why?
Acetanilides
1
2006
11
0.250
Why?
Stress Disorders, Post-Traumatic
2
2015
889
0.250
Why?
Program Development
3
2020
365
0.240
Why?
Managed Care Programs
1
2007
137
0.240
Why?
Contrast Media
3
2019
492
0.240
Why?
Blood Pressure
5
2014
1761
0.240
Why?
Cause of Death
8
2018
455
0.240
Why?
Home Care Services
2
2008
290
0.240
Why?
Piperidines
1
2008
223
0.240
Why?
Heart Valve Prosthesis
3
2017
127
0.230
Why?
Primary Health Care
4
2018
1768
0.230
Why?
Cardiovascular Surgical Procedures
1
2006
30
0.230
Why?
Physicians, Family
1
2007
179
0.230
Why?
Anticoagulants
4
2014
743
0.220
Why?
Length of Stay
6
2016
1342
0.220
Why?
Drug Therapy, Combination
6
2018
1034
0.220
Why?
Blood Vessel Prosthesis Implantation
1
2007
218
0.220
Why?
Diabetes Complications
1
2006
219
0.220
Why?
Pneumonia, Viral
2
2020
387
0.220
Why?
Coronavirus Infections
2
2020
379
0.220
Why?
Atherosclerosis
2
2008
410
0.220
Why?
Heart Valves
1
2005
44
0.210
Why?
Selection Bias
1
2004
38
0.210
Why?
Patient Care
2
2021
120
0.210
Why?
Metabolic Syndrome
1
2008
364
0.200
Why?
Pyrazoles
1
2008
516
0.200
Why?
Piperazines
1
2006
367
0.200
Why?
Adult
28
2021
40821
0.200
Why?
Health Care Costs
4
2016
418
0.200
Why?
Femoral Artery
3
2017
183
0.200
Why?
Atrial Flutter
2
2018
47
0.200
Why?
Interdisciplinary Communication
2
2015
200
0.200
Why?
Healthcare Disparities
3
2017
728
0.200
Why?
Coronary Occlusion
2
2017
20
0.200
Why?
Electrodes, Implanted
3
2013
113
0.190
Why?
Cooperative Behavior
4
2015
467
0.190
Why?
Health Services for the Aged
1
2003
73
0.190
Why?
United States Food and Drug Administration
3
2013
207
0.190
Why?
Forecasting
3
2021
386
0.180
Why?
Creatinine
7
2019
511
0.180
Why?
Cardiovascular System
1
2024
137
0.180
Why?
Exercise
3
2009
2206
0.180
Why?
Cardiac Rehabilitation
2
2016
46
0.180
Why?
Equipment Safety
2
2013
38
0.180
Why?
Mandatory Reporting
2
2015
45
0.180
Why?
Renal Insufficiency
1
2004
172
0.170
Why?
Infection Control
2
2021
174
0.170
Why?
Medical Records Systems, Computerized
2
2014
94
0.170
Why?
Postoperative Care
2
2018
292
0.170
Why?
Thrombolytic Therapy
3
2020
165
0.170
Why?
Time-to-Treatment
2
2014
257
0.170
Why?
ST Elevation Myocardial Infarction
2
2019
63
0.170
Why?
Consensus
2
2020
465
0.170
Why?
Cardiopulmonary Resuscitation
2
2016
334
0.160
Why?
Physician-Patient Relations
2
2018
595
0.160
Why?
Angioplasty
2
2011
48
0.160
Why?
Clinical Competence
4
2017
1261
0.160
Why?
Psychometrics
1
2004
708
0.160
Why?
Troponin I
2
2019
74
0.160
Why?
Betacoronavirus
2
2020
288
0.160
Why?
Health Services
1
2021
112
0.160
Why?
Off-Label Use
2
2017
50
0.160
Why?
Tomography, X-Ray Computed
1
2010
2766
0.150
Why?
Patient Admission
2
2019
216
0.150
Why?
Palliative Care
2
2009
1032
0.150
Why?
Reproducibility of Results
9
2019
3396
0.150
Why?
Tachycardia, Ventricular
1
2021
179
0.150
Why?
Confidence Intervals
7
2012
328
0.150
Why?
Mitral Valve
2
2018
96
0.150
Why?
Emergency Medicine
1
2002
278
0.150
Why?
Secondary Prevention
3
2014
247
0.150
Why?
Hospital Administration
3
2015
25
0.140
Why?
Computed Tomography Angiography
1
2020
151
0.140
Why?
Information Storage and Retrieval
1
2020
121
0.140
Why?
Cross-Sectional Studies
14
2016
5875
0.140
Why?
Decision Making, Computer-Assisted
1
2019
16
0.140
Why?
Statistics as Topic
3
2016
277
0.140
Why?
Chest Pain
3
2016
100
0.140
Why?
Prosthesis Implantation
2
2010
155
0.140
Why?
Drug Utilization
4
2015
170
0.140
Why?
Shock, Cardiogenic
4
2014
65
0.140
Why?
Decision Making
4
2016
987
0.140
Why?
Patient Care Management
1
2019
54
0.140
Why?
Blood Pressure Determination
3
2010
143
0.140
Why?
Echocardiography
4
2017
645
0.140
Why?
Inpatients
3
2016
538
0.140
Why?
Japan
4
2021
149
0.140
Why?
Research Report
2
2016
89
0.140
Why?
Datasets as Topic
2
2019
120
0.140
Why?
Mental Health
3
2016
771
0.140
Why?
Electrocardiography, Ambulatory
1
2018
64
0.140
Why?
Angiotensin Receptor Antagonists
2
2010
115
0.130
Why?
Markov Chains
2
2016
128
0.130
Why?
Monte Carlo Method
2
2016
150
0.130
Why?
Europe
2
2017
420
0.130
Why?
Socioeconomic Factors
4
2009
1323
0.130
Why?
Pneumonia
3
2016
633
0.130
Why?
Reimbursement, Incentive
2
2008
42
0.130
Why?
Aortic Stenosis, Subvalvular
1
2017
4
0.130
Why?
Medication Errors
2
2016
86
0.130
Why?
Elective Surgical Procedures
3
2016
203
0.130
Why?
Smartphone
1
2018
103
0.130
Why?
Aortic Valve Insufficiency
1
2017
43
0.130
Why?
American Medical Association
2
2013
19
0.130
Why?
Referral and Consultation
4
2015
878
0.130
Why?
Risk Adjustment
4
2013
83
0.130
Why?
Algorithms
3
2021
1843
0.120
Why?
Prasugrel Hydrochloride
1
2016
22
0.120
Why?
Age Distribution
5
2013
395
0.120
Why?
Congresses as Topic
1
2018
226
0.120
Why?
Clinical Trials as Topic
3
2018
1062
0.120
Why?
Thrombosis
3
2018
397
0.120
Why?
Surgeons
1
2021
337
0.120
Why?
Heart Arrest
2
2013
410
0.120
Why?
Communication
3
2016
979
0.120
Why?
Blood Transfusion
2
2017
393
0.120
Why?
Computers
1
2016
65
0.120
Why?
Drug Interactions
2
2009
403
0.120
Why?
Endarterectomy, Carotid
2
2014
63
0.120
Why?
Kaplan-Meier Estimate
6
2017
959
0.120
Why?
International Cooperation
1
2016
192
0.120
Why?
Health Care Surveys
5
2011
538
0.120
Why?
Insurance, Health
3
2013
315
0.110
Why?
Exercise Tolerance
2
2008
288
0.110
Why?
Mobility Limitation
1
2016
66
0.110
Why?
Deprescriptions
1
2016
38
0.110
Why?
Interprofessional Relations
1
2018
274
0.110
Why?
Drug Substitution
1
2015
62
0.110
Why?
Workload
1
2017
169
0.110
Why?
Medical Record Linkage
1
2015
68
0.110
Why?
Pandemics
2
2020
1700
0.110
Why?
Saphenous Vein
1
2014
36
0.100
Why?
Social Determinants of Health
1
2019
315
0.100
Why?
Vitamin K
1
2014
46
0.100
Why?
beta-Alanine
1
2014
25
0.100
Why?
Gated Blood-Pool Imaging
1
2013
6
0.100
Why?
Andropause
1
2013
5
0.100
Why?
Chronic Disease
6
2017
1824
0.100
Why?
Artificial Intelligence
1
2019
385
0.100
Why?
Antithrombins
1
2014
70
0.100
Why?
Community Health Services
2
2013
229
0.100
Why?
Postoperative Period
2
2005
344
0.100
Why?
Contraindications
4
2016
88
0.100
Why?
Hyperkalemia
1
2013
35
0.100
Why?
Cardiac Resynchronization Therapy
1
2014
63
0.100
Why?
Community-Based Participatory Research
1
2014
172
0.100
Why?
Patient Safety
2
2016
351
0.100
Why?
Drug Prescriptions
1
2015
290
0.100
Why?
Pyridines
2
2008
606
0.090
Why?
Pharmacy Service, Hospital
1
2014
90
0.090
Why?
No-Reflow Phenomenon
1
2012
7
0.090
Why?
Mineralocorticoid Receptor Antagonists
1
2013
69
0.090
Why?
Outpatients
1
2016
437
0.090
Why?
Health Care Reform
1
2014
109
0.090
Why?
Benzimidazoles
1
2014
189
0.090
Why?
Gait
1
2016
316
0.090
Why?
Prosthesis Design
1
2015
357
0.090
Why?
Equipment Failure
1
2013
111
0.090
Why?
Silicones
1
2012
30
0.090
Why?
Sex Distribution
3
2013
379
0.090
Why?
Coronary Circulation
2
2012
134
0.090
Why?
Asthma
1
2004
1800
0.090
Why?
Medically Uninsured
2
2013
134
0.090
Why?
Dose-Response Relationship, Drug
2
2008
2018
0.090
Why?
Hypertension, Pulmonary
2
2016
1957
0.090
Why?
Insurance Claim Review
1
2012
85
0.080
Why?
Biomarkers
7
2019
4329
0.080
Why?
Ventricular Dysfunction, Left
3
2010
391
0.080
Why?
Systole
3
2009
179
0.080
Why?
Poisson Distribution
2
2008
77
0.080
Why?
Ventricular Function, Left
3
2013
541
0.080
Why?
Clinical Medicine
1
2011
26
0.080
Why?
Heart Function Tests
3
2005
59
0.080
Why?
Longitudinal Studies
7
2016
3005
0.080
Why?
Documentation
1
2013
202
0.080
Why?
Automation
1
2010
104
0.080
Why?
Epidemiologic Methods
1
2010
91
0.080
Why?
Ventricular Outflow Obstruction
1
2010
38
0.080
Why?
Combined Modality Therapy
3
2008
1269
0.080
Why?
Policy
1
2011
147
0.080
Why?
Warfarin
2
2008
179
0.080
Why?
Organizational Innovation
2
2021
123
0.080
Why?
Heart Conduction System
2
2007
96
0.080
Why?
Hemodynamics
1
2015
1114
0.070
Why?
Testosterone
1
2013
419
0.070
Why?
Kidney Diseases
3
2009
427
0.070
Why?
Glomerular Filtration Rate
3
2014
743
0.070
Why?
Activities of Daily Living
2
2010
438
0.070
Why?
Enoxaparin
1
2009
68
0.070
Why?
Linear Models
4
2016
847
0.070
Why?
Public Health Informatics
1
2008
10
0.070
Why?
Phenotype
1
2017
3186
0.070
Why?
State Health Plans
1
2008
28
0.070
Why?
Carotid Stenosis
1
2010
103
0.070
Why?
Research
3
2008
421
0.070
Why?
Peptides
2
2016
991
0.070
Why?
Safety
1
2010
346
0.070
Why?
Ventricular Dysfunction
1
2008
16
0.070
Why?
Clinical Protocols
1
2010
279
0.070
Why?
Information Services
1
2008
42
0.070
Why?
Colorado
4
2010
4588
0.070
Why?
Heart Ventricles
1
2013
762
0.070
Why?
Feasibility Studies
1
2013
1125
0.070
Why?
Spirituality
1
2009
88
0.070
Why?
Coronary Care Units
1
2007
27
0.070
Why?
Intraoperative Complications
2
2012
154
0.070
Why?
Embolization, Therapeutic
1
2010
246
0.060
Why?
Angioplasty, Balloon
1
2008
92
0.060
Why?
Rehabilitation
1
2007
20
0.060
Why?
Efficiency, Organizational
1
2008
142
0.060
Why?
Disease Progression
4
2017
2857
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2016
1403
0.060
Why?
Personnel Turnover
1
2007
40
0.060
Why?
California
2
2006
473
0.060
Why?
Tomography, X-Ray
1
2006
4
0.060
Why?
Ranolazine
1
2006
23
0.060
Why?
Attitude of Health Personnel
2
2016
1212
0.060
Why?
Societies, Nursing
1
2006
28
0.060
Why?
Clinical Decision-Making
2
2021
364
0.060
Why?
District of Columbia
2
2018
37
0.060
Why?
ROC Curve
2
2009
613
0.060
Why?
Cyclooxygenase Inhibitors
1
2006
82
0.060
Why?
Echocardiography, Transesophageal
1
2007
132
0.060
Why?
Cluster Analysis
1
2008
494
0.060
Why?
Office Visits
1
2006
93
0.060
Why?
Peptide Fragments
1
2010
693
0.060
Why?
Drug Utilization Review
2
2016
60
0.060
Why?
Peripheral Vascular Diseases
1
2006
102
0.060
Why?
Demography
1
2006
274
0.060
Why?
Hospitals, High-Volume
2
2017
49
0.060
Why?
Michigan
2
2019
134
0.060
Why?
Survivors
1
2009
521
0.060
Why?
Heart Defects, Congenital
1
2013
920
0.060
Why?
Gastrointestinal Diseases
1
2007
220
0.060
Why?
Analysis of Variance
2
2007
1293
0.060
Why?
Diagnostic Errors
1
2006
178
0.050
Why?
Physical Endurance
1
2006
278
0.050
Why?
Natriuretic Peptide, Brain
1
2005
110
0.050
Why?
Refusal to Participate
1
2004
6
0.050
Why?
Symptom Assessment
2
2016
137
0.050
Why?
Terminology as Topic
2
2007
253
0.050
Why?
Sirolimus
1
2006
282
0.050
Why?
Troponin T
2
2019
63
0.050
Why?
Propensity Score
2
2021
370
0.050
Why?
Antipsychotic Agents
1
2006
178
0.050
Why?
Animals
2
2018
38030
0.050
Why?
Advisory Committees
2
2017
228
0.050
Why?
Medicaid
1
2008
472
0.050
Why?
Guidelines as Topic
1
2006
267
0.050
Why?
Diastole
1
2004
147
0.050
Why?
Body Mass Index
2
2015
2446
0.050
Why?
Probability
1
2004
308
0.050
Why?
Life Style
1
2006
495
0.050
Why?
Self-Assessment
1
2003
74
0.050
Why?
Patient Reported Outcome Measures
2
2018
502
0.050
Why?
Drug Labeling
2
2016
36
0.050
Why?
Case-Control Studies
3
2016
3633
0.040
Why?
Biomedical Research
1
2008
724
0.040
Why?
Emergency Treatment
1
2002
122
0.040
Why?
Disability Evaluation
1
2003
297
0.040
Why?
Utah
1
2021
82
0.040
Why?
Pediatrics
1
2009
1122
0.040
Why?
Adolescent
2
2013
22451
0.040
Why?
Patient Acceptance of Health Care
2
2018
880
0.040
Why?
Asia
1
2020
69
0.040
Why?
Child, Preschool
2
2013
11888
0.040
Why?
Latin America
1
2020
96
0.040
Why?
Health Behavior
2
2003
801
0.040
Why?
Insurance Coverage
2
2014
246
0.040
Why?
Observational Studies as Topic
1
2020
133
0.040
Why?
Confidentiality
1
2019
82
0.040
Why?
Public-Private Sector Partnerships
1
2019
44
0.040
Why?
Obesity
2
2015
3123
0.030
Why?
Medication Adherence
2
2015
535
0.030
Why?
Fee-for-Service Plans
2
2009
98
0.030
Why?
Protective Factors
1
2018
97
0.030
Why?
Interviews as Topic
2
2016
926
0.030
Why?
National Heart, Lung, and Blood Institute (U.S.)
2
2008
103
0.030
Why?
Databases as Topic
2
2009
70
0.030
Why?
Administration, Oral
2
2014
867
0.030
Why?
Self-Management
1
2021
207
0.030
Why?
Life Tables
2
2009
21
0.030
Why?
Pragmatic Clinical Trials as Topic
1
2018
135
0.030
Why?
Practice Management, Medical
1
2018
28
0.030
Why?
Alcoholism
1
2004
830
0.030
Why?
Child
3
2013
22638
0.030
Why?
Reference Values
1
2019
787
0.030
Why?
Stroke Volume
2
2013
651
0.030
Why?
Intersectoral Collaboration
1
2018
64
0.030
Why?
Reimbursement Mechanisms
1
2018
78
0.030
Why?
Punctures
1
2017
40
0.030
Why?
Hospitals, Low-Volume
1
2017
25
0.030
Why?
Transfusion Reaction
1
2017
61
0.030
Why?
Coronary Thrombosis
1
2016
25
0.030
Why?
Up-Regulation
1
2019
840
0.030
Why?
Non-ST Elevated Myocardial Infarction
1
2016
26
0.030
Why?
Likelihood Functions
1
2016
138
0.030
Why?
Cost-Benefit Analysis
2
2012
632
0.030
Why?
Immunoglobulin Fab Fragments
1
2016
55
0.030
Why?
Hypesthesia
1
2016
21
0.030
Why?
Transportation
1
2016
54
0.030
Why?
Neoplasms
2
2009
2944
0.030
Why?
Germany
1
2016
139
0.030
Why?
Diagnosis, Differential
1
2020
1500
0.030
Why?
Public Health
2
2013
573
0.030
Why?
Medication Reconciliation
1
2015
31
0.030
Why?
Frail Elderly
1
2016
136
0.030
Why?
Hospital Bed Capacity
1
2014
27
0.030
Why?
Operative Time
1
2015
192
0.030
Why?
Bioprosthesis
1
2014
39
0.030
Why?
Bayes Theorem
1
2016
424
0.030
Why?
Polypharmacy
1
2015
94
0.030
Why?
Aftercare
1
2016
221
0.030
Why?
Dabigatran
1
2014
30
0.030
Why?
Drug Hypersensitivity
1
2015
93
0.030
Why?
Hospitals, Urban
1
2014
140
0.030
Why?
Small-Area Analysis
1
2013
6
0.030
Why?
San Francisco
2
2004
60
0.030
Why?
Ischemic Attack, Transient
1
2014
71
0.030
Why?
Medical Assistance
1
2013
13
0.030
Why?
Magnetic Resonance Imaging
1
2006
3917
0.020
Why?
Metals
1
2014
137
0.020
Why?
Coronary Artery Bypass, Off-Pump
1
2013
16
0.020
Why?
Societies
1
2013
40
0.020
Why?
Potassium
1
2013
151
0.020
Why?
Administrative Personnel
1
2013
33
0.020
Why?
Pilot Projects
2
2010
1878
0.020
Why?
Medical Audit
1
2012
77
0.020
Why?
Health Status Disparities
1
2015
321
0.020
Why?
Comparative Effectiveness Research
1
2012
170
0.020
Why?
Thoracic Surgery
1
2013
142
0.020
Why?
Radiography
1
2013
856
0.020
Why?
Nitrates
1
2011
97
0.020
Why?
Cardiopulmonary Bypass
1
2013
217
0.020
Why?
Insurance Claim Reporting
1
2010
25
0.020
Why?
Graft Survival
1
2013
508
0.020
Why?
Hirudins
1
2010
52
0.020
Why?
Health Maintenance Organizations
1
2010
105
0.020
Why?
Feedback
1
2011
180
0.020
Why?
Hospitals, Private
1
2009
12
0.020
Why?
Retreatment
1
2009
79
0.020
Why?
Ultrasonography
1
2013
788
0.020
Why?
Graft Rejection
1
2013
504
0.020
Why?
Pressure
1
2010
221
0.020
Why?
Medication Therapy Management
1
2010
73
0.020
Why?
Diagnosis-Related Groups
1
2008
32
0.020
Why?
Antibodies, Monoclonal
1
2016
1511
0.020
Why?
Utilization Review
1
2008
37
0.020
Why?
Hypolipidemic Agents
1
2009
89
0.020
Why?
Validation Studies as Topic
1
2008
23
0.020
Why?
Chemotherapy, Adjuvant
1
2010
429
0.020
Why?
Hematocrit
1
2008
108
0.020
Why?
Economics, Hospital
1
2008
28
0.020
Why?
Leadership
1
2013
410
0.020
Why?
Qualitative Research
1
2016
1720
0.020
Why?
Medical History Taking
1
2008
116
0.020
Why?
Time and Motion Studies
1
2007
28
0.020
Why?
Evidence-Based Practice
1
2010
230
0.020
Why?
Least-Squares Analysis
1
2007
73
0.020
Why?
Creatine Kinase, MB Form
1
2007
6
0.020
Why?
Observation
1
2007
51
0.020
Why?
Models, Cardiovascular
1
2008
194
0.020
Why?
Pulmonary Disease, Chronic Obstructive
2
2006
926
0.020
Why?
Recombinant Proteins
1
2010
1361
0.020
Why?
Kidney
1
2014
1491
0.020
Why?
Sentinel Surveillance
1
2006
48
0.020
Why?
Reperfusion
1
2006
53
0.020
Why?
Factor Analysis, Statistical
1
2007
295
0.020
Why?
Health Personnel
1
2013
750
0.010
Why?
Canada
1
2007
430
0.010
Why?
Organizational Culture
1
2007
159
0.010
Why?
Drug Implants
1
2006
83
0.010
Why?
Anemia
1
2007
189
0.010
Why?
Vascular Diseases
1
2008
251
0.010
Why?
Cerebrovascular Disorders
1
2006
103
0.010
Why?
Training Support
1
2005
35
0.010
Why?
Point-of-Care Systems
1
2007
185
0.010
Why?
Attitude
1
2007
253
0.010
Why?
Delphi Technique
1
2006
347
0.010
Why?
Patients
1
2006
183
0.010
Why?
Antidepressive Agents
1
2006
234
0.010
Why?
National Institutes of Health (U.S.)
1
2005
147
0.010
Why?
Diagnostic Tests, Routine
1
2005
108
0.010
Why?
Drug Administration Schedule
1
2006
782
0.010
Why?
Recurrence
1
2007
1125
0.010
Why?
Disease-Free Survival
1
2006
777
0.010
Why?
Echocardiography, Stress
1
2003
29
0.010
Why?
Intra-Aortic Balloon Pumping
1
2003
19
0.010
Why?
Social Support
1
2007
644
0.010
Why?
Washington
1
2002
157
0.010
Why?
Population Surveillance
1
2005
477
0.010
Why?
Dementia
1
2006
322
0.010
Why?
Sensitivity and Specificity
1
2005
1992
0.010
Why?
Lung Diseases
1
2007
787
0.010
Why?
Reoperation
1
2003
633
0.010
Why?
Urban Population
1
2002
496
0.010
Why?
Infant, Newborn
1
2009
6449
0.010
Why?
Hypoglycemic Agents
1
2006
1411
0.010
Why?
Infant
1
2009
10093
0.010
Why?
Rumsfeld's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)